A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination With Atorvastatin, Simvastatin, and Rosuvastatin in Patients With Hypercholesterolemia or Low HDL-C

Trial Profile

A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination With Atorvastatin, Simvastatin, and Rosuvastatin in Patients With Hypercholesterolemia or Low HDL-C

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2015

At a glance

  • Drugs Evacetrapib (Primary) ; Atorvastatin; Rosuvastatin; Simvastatin
  • Indications Hypercholesterolaemia; Low HDL cholesterol
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 17 Nov 2015 Results published in the Journal of the American College of Cardiology
    • 16 Nov 2011 Results published in JAMA: the Journal of the American Medical Association.
    • 13 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top